Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Healthcare (Basel, Switzerland)
|
April 12, 2025
A Qualitative Study Exploring the Rehabilitation Experience of Individuals with a Previous Diagnosis of Cancer and/or Sepsis, Their Caregivers, and Health Providers
Jenna Smith-Turchyn, Christopher Farley, Anastasia N L Newman, et al.
CJC Open
|
December 13, 2021
Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis
Muhammad Mustafa Alhussein, Abir Mokbel, Tammy Cosman, et al.
Canadian Medical Education Journal
|
May 17, 2021
Ten ways to get a grip on designing and implementing a competency-based medical education training program
Tina Hsu, Flávia De Angelis, Sohaib Al-Asaaed, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
April 11, 2026
Monitoring Upper Extremity Function of Individuals With Breast Cancer: Development and Usability of the <i>StrongArms-Cancer</i> mHealth System
Jenna Smith-Turchyn, Jordon L Hvizd, Edward R Sykes, et al.
Investigational New Drugs
|
March 2, 2010
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium
Srikala S Sridhar, Eric Winquist, Andrea Eisen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2011
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c
Fred Saad, Sebastien Hotte, Scott North, et al.
NPJ Breast Cancer
|
March 6, 2020
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer
Pamela J Goodwin, Roanne J Segal, Michael Vallis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2022
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)
Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, et al.
Scientific Reports
|
July 18, 2025
Implementing exercise and self-management for women with breast cancer during treatment: results of the NEXT-BRCA randomized controlled trial
Jenna Smith-Turchyn, Derek W Stouth, Joshua A J Keogh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 9, 2019
Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
Eric K Nguyen, Hang Yu, Gregory Pond, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Healthcare (Basel, Switzerland)
|
April 12, 2025
A Qualitative Study Exploring the Rehabilitation Experience of Individuals with a Previous Diagnosis of Cancer and/or Sepsis, Their Caregivers, and Health Providers
Jenna Smith-Turchyn, Christopher Farley, Anastasia N L Newman, et al.
CJC Open
|
December 13, 2021
Pertuzumab Cardiotoxicity in Patients With HER2-Positive Cancer: A Systematic Review and Meta-analysis
Muhammad Mustafa Alhussein, Abir Mokbel, Tammy Cosman, et al.
Canadian Medical Education Journal
|
May 17, 2021
Ten ways to get a grip on designing and implementing a competency-based medical education training program
Tina Hsu, Flávia De Angelis, Sohaib Al-Asaaed, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing
|
April 11, 2026
Monitoring Upper Extremity Function of Individuals With Breast Cancer: Development and Usability of the <i>StrongArms-Cancer</i> mHealth System
Jenna Smith-Turchyn, Jordon L Hvizd, Edward R Sykes, et al.
Investigational New Drugs
|
March 2, 2010
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium
Srikala S Sridhar, Eric Winquist, Andrea Eisen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 27, 2011
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c
Fred Saad, Sebastien Hotte, Scott North, et al.
NPJ Breast Cancer
|
March 6, 2020
The LISA randomized trial of a weight loss intervention in postmenopausal breast cancer
Pamela J Goodwin, Roanne J Segal, Michael Vallis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2022
Durvalumab Plus Olaparib in Previously Untreated, Platinum-Ineligible Patients With Metastatic Urothelial Carcinoma: A Multicenter, Randomized, Phase II Trial (BAYOU)
Jonathan E Rosenberg, Se Hoon Park, Vadim Kozlov, et al.
Scientific Reports
|
July 18, 2025
Implementing exercise and self-management for women with breast cancer during treatment: results of the NEXT-BRCA randomized controlled trial
Jenna Smith-Turchyn, Derek W Stouth, Joshua A J Keogh, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
November 9, 2019
Outcomes of trimodality bladder-sparing therapy for muscle-invasive bladder cancer
Eric K Nguyen, Hang Yu, Gregory Pond, et al.
Page
of 6